N

Nordhealth AS
OSE:NORDH

Watchlist Manager
Nordhealth AS
OSE:NORDH
Watchlist
Price: 37 NOK 2.78% Market Closed
Market Cap: kr2.9B

Wall Street
Price Targets

NORDH Price Targets Summary
Nordhealth AS

Wall Street analysts forecast NORDH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NORDH is 40.8 NOK with a low forecast of 40.4 NOK and a high forecast of 42 NOK.

Lowest
Price Target
40.4 NOK
9% Upside
Average
Price Target
40.8 NOK
10% Upside
Highest
Price Target
42 NOK
14% Upside
Nordhealth AS Competitors:
Price Targets
TMP
Tompkins Financial Corp
2% Upside
CIM
Chimera Investment Corp
20% Upside
CORE
Allcore SpA
97% Upside
DRT
DIRTT Environmental Solutions Ltd
78% Upside
MGNX
MacroGenics Inc
80% Upside

Revenue
Forecast

21% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-91%
Average Miss
21% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-91%
Average Miss

For the last 2 years the compound annual growth rate for Nordhealth AS's revenue is 21%. The projected CAGR for the next 3 years is 16%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-83%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-83%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NORDH's stock price target?
Price Target
40.8 NOK

According to Wall Street analysts, the average 1-year price target for NORDH is 40.8 NOK with a low forecast of 40.4 NOK and a high forecast of 42 NOK.

What is Nordhealth AS's Revenue forecast?
Projected CAGR
16%

For the last 2 years the compound annual growth rate for Nordhealth AS's revenue is 21%. The projected CAGR for the next 3 years is 16%.

Back to Top